COLA Appoints Mark Tatelbaum as Chief Counsel

COLA, a nationally recognized private, non-profit laboratory accreditation organization, has announced the appointment of Mark Tatelbaum as Chief Counsel. Tatelbaum joins COLA having extensive legal experience in healthcare and, more specifically, in the clinical laboratory sector. Tatelbaum recently served as the General Counsel for Ameritox, LLC, a national toxicology laboratory headquartered in Columbia, MD. Prior…

National Patient Safety Awareness Week 2019

COLA Supports 2019 National Patient Safety Awareness Week

Thirteen billion clinical laboratory tests are performed annually in clinical laboratories nationwide. These test results are relied upon by thousands of physicians each and every day to make important decisions about diagnosis and treatment in collaboration with their patients, and COLA is honored to serve the tens of thousands of professionals involved in laboratory testing…

CMS releases final Clinical Laboratory Fee Schedule

COLA Receives Deeming Authority for Another Six Years

The Centers for Medicare and Medicaid Services (CMS) has renewed COLA’s deeming authority for another six years under the Clinical Laboratory Improvement Amendments of 1988 (CLIA 88). COLA is a private, non-profit laboratory accreditation organization accrediting clinical laboratories nationwide. Six years is the maximum period an accrediting organization can be given deeming authority before its…

implementation of rate cuts

COLA requests expansion of GAO report on PAMA

COLA, a nationally recognized private, non-profit laboratory accreditation organization, recently sent a letter to the U.S. Government Accountability Office (GAO) requesting an expansion of its recent report on the implementation of rate cuts to the Clinical Laboratory Fee Schedule (CLFS) do to PAMA. The GAO, in a November 2018 report entitled, “Medicare Laboratory Tests: Implementation…

COLA Appoints Nancy Stratton as Chief Executive Officer

COLA, the nation’s premier clinical laboratory accreditation provider, has announced the appointment of Nancy Stratton as Chief Executive Officer (CEO). A senior executive with more than 35 years of experience in laboratory management, Stratton will be responsible for driving the organization’s continued growth as it furthers its mission to promote excellence in laboratory medicine and…

PAMA’s actual effects

New survey out on the seriousness of PAMA

Under the Protecting Access to Medicare Act (PAMA), Congress changed the way Medicare determines rates for the Clinical Laboratory Fee Schedule (CLFS), and the implementation of PAMA led to a significant cut for a majority of the routine tests physicians use every day to care for their patients. The physician community has been increasingly concerned…

Biotin

BD Vacutainer Blood Collection Tubes by Becton, Dickinson and Company (BD): Class I Recall – Chemical Interference with Certain Tests

BD Vacutainer EDTA Lavender, Tan, and Pink Top Tubes BD Vacutainer Lithium Heparin Green Top Tube [Posted 03/23/2018] AUDIENCE: Risk Manager, Nursing, Laboratory ISSUE: BD is recalling their Vacutainer EDTA Blood Collection Tubes with lavender, tan, pink and green rubber tube stoppers due to a chemical in the rubber tube stopper that interferes with the…

COLA’s CEO praises medical laboratory professional for their dedication to patient health and safety

Even though they may not be in the spotlight, medical laboratory professionals assist in diagnosis and treatment by providing safe, relevant and accurate laboratory information to physicians and patients. They are a vital member of the care team and this week we celebrate their many gifts with the kick-off of National Medical Laboratory Professionals Week…